Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries

Mabel Berrueta, Jennifer Hemingway-Foday, Vanessa R Thorsten, Robert L Goldenberg, Waldemar A Carlo, Ana Garces, Archana Patel, Sarah Saleem, Omrana Pasha, Elwyn Chomba, Patricia L Hibberd, Nancy F Krebs, Shivaprasad Goudar, Richard J Derman, Fabian Esamai, Edward A Liechty, Janet L Moore, Elizabeth M McClure, Marion Koso-Thomas, Pierre M Buekens, José M Belizán, Fernando Althabe, Mabel Berrueta, Jennifer Hemingway-Foday, Vanessa R Thorsten, Robert L Goldenberg, Waldemar A Carlo, Ana Garces, Archana Patel, Sarah Saleem, Omrana Pasha, Elwyn Chomba, Patricia L Hibberd, Nancy F Krebs, Shivaprasad Goudar, Richard J Derman, Fabian Esamai, Edward A Liechty, Janet L Moore, Elizabeth M McClure, Marion Koso-Thomas, Pierre M Buekens, José M Belizán, Fernando Althabe

Abstract

Background: Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an effective intervention to reduce neonatal mortality among preterm babies delivered in hospital settings, but has not been widely used in low-middle resource settings. We sought to assess the rates of ACS use at all levels of health care in low and middle income countries (LMIC).

Methods: We assessed rates of ACS in 7 sites in 6 LMIC participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Global Network for Women and Children's Health Research Antenatal Corticosteroids Trial (ACT), a cluster-randomized trial to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of ACS. We conducted this analysis using data from the control clusters, which did not receive any components of the intervention and intended to follow usual care. We included women who delivered an infant with a birth weight <5th percentile, a proxy for preterm birth, and were enrolled in the Maternal Newborn Health (MNH) Registry between October 2011 and March 2014 in all clusters. A survey of the site investigators regarding existing policies on ACS in health facilities and for health workers in the community was part of pre-trial activities.

Results: Overall, of 51,523 women delivered in control clusters across all sites, the percentage of <5th percentile babies ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation among the sites in the use of ACS at all hospitals and among those hospitals having cesarean section and neonatal care capabilities (bag and mask and oxygen or mechanical ventilation). Rates of ACS use for <5th percentile babies in all hospitals ranged from 3.8 % in the Kenya sites to 44.5 % in the Argentina site, and in hospitals with cesarean section and neonatal care capabilities from 0 % in Zambia to 43.5 % in Argentina. ACS were rarely used in clinic or home deliveries at any site. Guidelines for ACS use at all levels of the health system were available for most of the sites.

Conclusion: Our study reports an overall low utilization of ACS among mothers of <5th percentile infants in hospital and clinic deliveries in LMIC.

Trial registration: clinicaltrials.gov ( NCT01084096 ).

References

    1. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40. doi: 10.1016/S0140-6736(14)61698-6.
    1. National Institutes of Health. The effect of corticosteroids for fetal maturation on perinatal outcomes. Consensus Development Conference Statement, Feb 28–March 2, 1994. Accessed 1 June 2014).
    1. Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn J. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol. 2010;39(suppl 1):i122–33. doi: 10.1093/ije/dyq029.
    1. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3
    1. Katz J, Lee AC, Kozuki N, Black RE, the CHERG Small-for-Gestational-Age-Preterm Birth Working Group Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382:417–25. doi: 10.1016/S0140-6736(13)60993-9.
    1. Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, for The Lancet Every Newborn Study Group et al. Every Newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205. doi: 10.1016/S0140-6736(14)60496-7.
    1. Bhutta ZA, Das JK, Bahl R, Lawn JE, Salam RA, Paul VK, for The Lancet Newborn Interventions Review Group. The Lancet Every Newborn Study Group et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet. 2014;384:347–70. doi: 10.1016/S0140-6736(14)60792-3.
    1. McClure EM, de Graft-Johnson J, Jobe AH, Wall S, Koblinsky M, Moran A, et al. A conference report on prenatal corticosteroid use in low- and middle-income countries. Int J Gynaecol Obstet. 2011;115:215–9. doi: 10.1016/j.ijgo.2011.07.017.
    1. Azad K, Costello A. Extreme caution is needed before scale-up of antenatal corticosteroids to reduce preterm deaths in low-income settings. Lancet Glob Health. 2014;2:e191–2. doi: 10.1016/S2214-109X(14)70020-8.
    1. Jehan I, Zaidi S, Rizvi S, Mobeen N, McClure EM, Munoz B, et al. Dating gestational age by last menstrual period, symphysis-fundal height, and ultrasound in urban Pakistan. Int J Gynaecol Obstet. 2010;110:231–4. doi: 10.1016/j.ijgo.2010.03.030.
    1. Garces A, McClure EM, Chomba E, et al. Home birth attendants in low income countries: who are they and what do they do? BMC Pregnancy Childbirth. 2012;12:34. doi: 10.1186/1471-2393-12-34.
    1. Dickson KE, Simen-Kapeu A, Kinney MV, Ashton J, Zaka N, Simen-Kapeu A, for The Lancet Every Newborn Study Group et al. Every Newborn: health-systems bottlenecks and strategies to accelerate scale-up in countries. Lancet. 2014;384:438–54. doi: 10.1016/S0140-6736(14)60582-1.
    1. Goudar S, Carlo W, McClure E, Patel A, Pasha O, Tshefu A, et al. The Maternal and Newborn Health Registry Study of the Global Network for Women's and Children's Health Research. Int J Gynaecol Obstet. 2012;118(3):190–3. doi: 10.1016/j.ijgo.2012.04.022.
    1. Althabe F, Belizán JM, Mazzoni A, Berrueta M, Hemingway-Foday J, Koso-Thomas M, et al. Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol. Reprod Health. 2012;9:22. doi: 10.1186/1742-4755-9-22.
    1. Althabe F, Berrueta M, Hemingway-Foday J, Mazzoni A, Bonorino CA, Gowdak A, et al. A color-coded tape for uterine height measurement: a tool to identify preterm pregnancies in low resource settings. PLoS One. 2015;10(3) doi: 10.1371/journal.pone.0117134.
    1. Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629–39. doi: 10.1016/S0140-6736(14)61651-2.
    1. WHO . Recommendations on Interventions to Improve Preterm Birth Outcomes. Geneva: World Health Organization; 2015.
    1. Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E, EmONC Trial Group et al. Assessment of obstetric and neonatal health services in developing country health facilities. Am J Perinatol. 2013;30(9):787–94. doi: 10.1055/s-0032-1333409.
    1. McClure EM, Goldenberg RL, Jobe AH, Miodovnik M, Koso-Thomas M, Buekens P, et al. Reducing neonatal mortality associated with preterm birth: Gaps in knowledge of the impact of antenatal corticosteroids on preterm birth in low-middle income countries Reproductive Health (in press)
    1. Vogel JP, Oladapo OT, Manu A, Gülmezoglu AM, Bahl R. New WHO recommendations to improve the outcomes of preterm birth. Lancet Glob Health. 2015;3(10):e589–90. doi: 10.1016/S2214-109X(15)00183-7.
    1. Vogel JP, Souza JP, Gülmezoglu AM, Mori R, Lumbiganon P, Qureshi Z, WHO Multi-Country Survey on Maternal and Newborn Health Research Network et al. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet. 2014;384(9957):1869–77. doi: 10.1016/S0140-6736(14)60580-8.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi